Headline
The latest stories from AHA Today.
Pfizer Inc. has completed enrolling children aged 12 to 15 in a COVID-19 vaccine study, the drug maker confirmed.
AHA today urged the Centers for Medicare & Medicaid Services to immediately withdraw its Most Favored Nation model interim final rule and “replace it with a serious effort at drug pricing reform.”
An estimated one in five people in the United States had a sexually transmitted infection at some point in 2018, with almost half of new infections in those under age 25, the Centers for Disease Control and Prevention reported.
In this Members in Action podcast, Julia Resnick, AHA senior program manager, speaks with leaders from CHI Health’s Creighton University Medical Center about how a culture enabled by interdisciplinary care teams is improving value for their patients.
As COVID-19 surges continue, lessons learned by health systems large and small reveal the importance of teamwork, communication, flexibility, preparation and supporting the physical and mental health of all staff.
The Commonwealth Fund issued a report outlining recommendations for federal investments in health.
The Centers for Disease Control and Prevention reported 10 cases of anaphylaxis, a life-threatening allergic reaction, among the more than 4 million people who received a first dose of the Moderna COVID-19 vaccine between Dec. 21, 2020, and Jan. 10, 2021.
Full-dose blood thinner treatments can reduce the need for vital organ support such as ventilation in moderately ill patients hospitalized for COVID-19, according to interim results from a clinical trial announced by the National Institutes of Health.
U.S. deaths involving methamphetamines increased more than five-fold from 2011 to 2018, to 10.1 per 100,000 men and 4.5 per 100,000 women, according to a study reported yesterday in JAMA Psychiatry.
This year’s AHA Rural Health Care Leadership Conference offers a unique opportunity for leaders to connect before, during and after the conference in affinity groups.